The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Assessment of Alzheimer’s disease case–control associations using family-based methods
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An association of CH25H with AD was first reported in a hippocampal microarray study of AD brain tissue [53] and further suggested by an AlzGene meta-analysis for a sporadic AD population [54] and other AD patient-based independent systematic analyses [55–57].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [56]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
Self-citationEckman, E. A., Adams, S. K., Troendle, F. J., Stodola, B. A., Kahn, M. A., Fauq, A. H., Xiao, H. D., Bernstein, K. E., & Eckman, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605827200 · Cited by 196 · cited 1×
“It remains to be shown, however, whether ACE’s Aβ degrading activity is also relevant in vivo: this was not supported in at least two recent reports [20, 21].”
Result
Flagged first, then by citations
Research works printed but not linked: 29
- Bertram L, Blacker D, Crystal A, Mullin K, Keeney D, Jones J et al (2000) Candidate genes showing no evidence for association or linkage with Alzheimer’s disease using family-based methodologies. Exp Gerontol 35:1353–1361. doi: 10.1016/S0531-5565(00)00193-5 · DOI
- Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F et al (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39:168–177. doi: 10.1038/ng1943 · DOI · Paper page
- Laird NM, Lange C (2006) Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet 7:385–394. doi: 10.1038/nrg1839 · DOI
- Blacker D, Haines JL, Rodes L, Terwedow H, Go RC, Harrell LE et al (1997) ApoE-4 and age at onset of Alzheimer’s disease: the NIMH genetics initiative. Neurology 48:139–147 · DOI · Paper page
- Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, Ramasamy K et al (2005) Family-based association between Alzheimer’s disease and variants in UBQLN1. N Engl J Med 352:884–894. doi: 10.1056/NEJMoa042765 · DOI
- Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC (2006) ACE polymorphisms. Circ Res 98:1123–1133. doi: 10.1161/01.RES.0000223145.74217.e7 · DOI
- Rabinowitz D, Laird N (2000) A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 50:211–223. doi: 10.1159/000022918 · DOI · Paper page
- Fisher RA (1932) Statistical methods for research workers. Oliver and Boyd, Edinburgh
- Witte JS, Gauderman WJ, Thomas DC (1999) Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol 149:693–705 · DOI
- DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. doi: 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Lange C, DeMeo D, Silverman EK, Weiss ST, Laird NM (2004) PBAT: tools for family-based association studies. Am J Hum Genet 74:367–369. doi: 10.1086/381563 · DOI · Paper page
- Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A et al (2007) Evidence for novel susceptibility genes for late-onset Alzheimer’s disease from a genome-wide association study of putative functional variants. Hum Mol Genet 16:865–873. doi: 10.1093/hmg/ddm031 · DOI · Paper page
- Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, Goate AM (2009) Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta. Neurogenetics. doi: 10.1007/s10048-008-0150-4 · DOI · Paper page
- Takeda S, Sato N, Ogihara T, Morishita R (2008) The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer’s disease: new therapeutic potential. Front Biosci 13:2253–2265. doi: 10.2741/2839 · DOI
- Keavney B, McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, Sobel E et al (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 7:1745–1751. doi: 10.1093/hmg/7.11.1745 · DOI
- Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B et al (2003) Haplotypes extending across ACE are associated with Alzheimer’s disease. Hum Mol Genet 12:859–867. doi: 10.1093/hmg/ddg094 · DOI
- Miners JS, Ashby E, Van Helmond Z, Chalmers KA, Palmer LE, Love S et al (2008) Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer’s disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 34:181–193. doi: 10.1111/j.1365–2990.2007.00885.x · DOI
- Hu J, Igarashi A, Kamata M, Nakagawa H (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 276:47863–47868 · DOI
- Hemming ML, Selkoe DJ, Farris W (2007) Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease. Neurobiol Dis 26:273–281 · DOI
- Brewer GJ (2007) Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer’s disease. Exp Biol Med (Maywood) 232:323–335
- Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ et al (1995) Transferrin and iron in normal, Alzheimer’s disease, and Parkinson’s disease brain regions. J Neurochem 65:710–724 · DOI · Paper page
- Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 94:9866–9868. doi: 10.1073/pnas.94.18.9866 · DOI
- Yamamoto A, Shin RW, Hasegawa K, Naiki H, Sato H, Yoshimasu F et al (2002) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer’s disease. J Neurochem 82:1137–1147 · DOI · Paper page
- Lee PL, Ho NJ, Olson R, Beutler E (1999) The effect of transferrin polymorphisms on iron metabolism. Blood Cells Mol Dis 25:374–379. doi: 10.1006/bcmd.1999.0267 · DOI
- Zatta P, Messori L, Mauri P, van Rensburg SJ, van Zyl J, Gabrielli S et al (2005) The C2 variant of human serum transferrin retains the iron binding properties of the native protein. Biochim Biophys Acta 1741:264–270 · DOI
- Kalamida D, Poulas K, Avramopoulou V, Fostieri E, Lagoumintzis G, Lazaridis K et al (2007) Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity. FEBS J 274:3799–3845. doi: 10.1111/j.1742–4658.2007.05935.x · DOI
- Oddo S, LaFerla FM (2006) The role of nicotinic acetylcholine receptors in Alzheimer’s disease. J Physiol (Paris) 99:172–179. doi: 10.1016/j.jphysparis.2005.12.080 · DOI
- Tohgi H, Utsugisawa K, Yoshimura M, Nagane Y, Mihara M (1998) Age-related changes in nicotinic acetylcholine receptor subunits alpha4 and beta2 messenger RNA expression in postmortem human frontal cortex and hippocampus. Neurosci Lett 245:139–142. doi: 10.1016/S0304-3940(98)00205-5 · DOI
- Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349–1356. doi: 10.1001/jama.278.16.1349 · DOI · Paper page
Cited by
Sorted by citations
Bertram, L., Lange, C., Mullin, K., Parkinson, M., Hsiao, M., Hogan, M. F., Schjeide, B. M. M., Hooli, B., DiVito, J., Ionita, I., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.10.008 · Cited by 511
Self-citationKim, M., Suh, J., Romano, D., Truong, M. H., Mullin, K., Hooli, B., Norton, D., Tesco, G., Elliott, K., Wagner, S. L., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp323 · Cited by 234
Self-citationKehoe, P. G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171119 · Cited by 133
25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner
Wong, M. Y., Lewis, M., Doherty, J. J., Shi, Y., Cashikar, A. G., Amelianchik, A., Tymchuk, S., Sullivan, P. M., Qian, M., Covey, D. F., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01869-3 · Cited by 121
Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta
Kauwe, J. S. K., Wang, J., Mayo, K., Morris, J. C., Fagan, A. M., Holtzman, D. M., & Goate, A. M. (2009) · neurogenetics · doi:10.1007/s10048-008-0150-4 · Cited by 82
Metadata
- Authors
- Schjeide, B.-M. M., McQueen, M. B., Mullin, K., DiVito, J., Hogan, M. F., Parkinson, M., Hooli, B., Lange, C., Blacker, D., Tanzi, R. E., & Bertram, L.
- Venue
- neurogenetics
- Published
- 2008-10-02
- Volume
- 10
- Issue
- 1
- Pages
- 19-25
- ISSN
- 1364-6745
- 1364-6753
- PMC
- PMC2841132
- Cited by
- 57
- References
- 2
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
